Alkem Laboratories Receives Favorable Income Tax Appellate Orders Worth ₹660.77 Crore Relief

Key Metrics:

What Happened ?

Key Details

Tax Appeal Outcome:

• Commissioner of Income Tax (Appeals)-47, Mumbai passed favorable appellate orders.
• Orders relate to Assessment Years:
  • AY 2018-19
  • AY 2019-20
  • AY 2020-21
  • AY 2021-22
  • AY 2022-23
• The appellate authority deleted disallowances made under Section 80-IE of the Income-tax Act.
• Total tax amount involved:
  • ₹660.77 crore
• The original disallowances arose from reassessment orders passed under Sections 143(3)/144 read with Section 147 of the Income-tax Act.
• Orders were received on June 30, 2026.

Note:

• While the appellate decision removes the disputed tax disallowances at this stage, the company has not disclosed whether the tax department intends to pursue further legal remedies.

Risk Analysis

Summary:

• The appellate orders are favorable and reduce tax uncertainty for the relevant assessment years. However, tax litigation may continue if challenged by the revenue authorities through higher appellate forums.

Key Risks:

• Revenue authorities may choose to appeal against the CIT(A) orders.
• Final tax resolution may depend on subsequent judicial proceedings.
• The disclosure does not indicate whether further appeals are expected.

Worst Case:

• If the tax authorities challenge the appellate orders successfully before a higher judicial forum, the disputed tax liability could re-emerge.

Risk Level: Low

Company Commentary

• It has received favorable Orders-in-Appeal from the Commissioner of Income Tax (Appeals)-47, Mumbai.
• The appellate authority deleted tax disallowances under Section 80-IE for AY 2018-19 to AY 2022-23.
• The tax amount involved is ₹660.77 crore.
• The orders were received on June 30, 2026.
• The company believes there is no material impact on its financial position, operations, or other business activities arising from these orders.